针对眼睛的A20基因疗法通过减少病态神经血管化,化和神经细胞亡来缓解缺血性视网膜病变
Sanah Essayagh1, Tarek Aridi1, Tytteli Turunen1
1Department of Surgery, The Division of Vascular and Endovascular Surgery and the Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
概括
A20基因疗法为增殖性视网膜病变提供了一种新的治疗方法,通过同时减少病态新血管化,炎症和神经元细胞死亡,改善抗VEGF疗法失败的结果.
科学领域:
- 眼科医生 眼科 眼科
- 分子生物学分子生物学
- 基因治疗 基因治疗
背景情况:
- 内抗VEGF疗法是扩散性视网膜病变 (PR) 的标准,但在四分之一的患者中有效性有限.
- PR病原发生涉及病态血管生成,炎症性化和神经元亡之间的复杂相互作用.
- 针对这些多重因素提供了改善治疗结果的潜在策略.
研究的目的:
- 研究NF-κB抑制剂A20/TNFAIP3在血管生成调节中的作用及其作为PR治疗点的潜力.
- 评估A20基因治疗在氧气诱导的增殖性视网膜病变的小鼠模型中的疗效.
主要方法:
- 在人类视网膜内皮细胞和氧诱导PR的小鼠模型中,研究了A20的功能增加和丧失.
- 体内A20基因疗法交付和对其对新血管化,化和亡的影响的评估.
- 使用质纤维酸蛋白 (GFAP) 和谷氨酸合成酶 (GS) 免疫染来评估质功能.
主要成果:
- 鉴定出A20是血管生成的一个生理调节剂.
- 在小鼠PR模型中,Intravitreal A20基因疗法显著降低了血管消灭和新血管形.
- A20疗法降低了炎症性结晶体,改善了结晶体功能 (穆勒细胞),并减少了神经元和整体视网膜细胞亡.
结论:
- A20在调节视网膜血管生成,炎症和细胞存活方面发挥着至关重要的作用.
- A20基因疗法通过同时解决关键疾病机制,证明了多发性视网膜病变的显著治疗潜力.
- A20代表了一个有前途的新型治疗标,用于改善目前对抗VEGF治疗无反应的患者的治疗结果.
相关概念视频
01:27Open Angle Glaucoma: Treatment
917
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
917
01:28Angle Closure Glaucoma: Treatment
1.1K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K
00:59Gene Therapy
27.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.3K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:25Glaucoma: Overview
1.2K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.2K